Using this strategy, Kalbaugh et al. assigned affinity and efficacy roles to positions during the LBDs in the NR1 and NR2A NMDAR subunits. In situ mutation of residues in direct contact with bound ligand impacted the two efficacy and affinity, though positions that stabilize the shut cleft conformation with no direct ligand interaction contributed